Promoter holding
64.27%
FL
Famy Life Sciences Private Limited - Due diligence report
A 360° intelligence report on Famycare: trust score, financial health, credit view, compliance, directors, growth and distress signals - gen…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Famycare — 360° Intelligence Report
Generated from MCA filings & public records86/100
Trust Score
Low Risk
Famycare is assessed as Low Risk with a Trust Score of 86/100. Famycare is an active private limited indian non-government company incorporated in 2008, operating in the Trading sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 26 Jun 2026 from the latest processed filings. Famy Life Sciences Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
86/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
86/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- No open charges - unencumbered balance sheet.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 2 satisfied (110.00 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 1 | 48.0 cr |
| Hdfc Bank Limited | 1 | 48.0 cr |
Compliance Score: 86/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- 5 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 85/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| AJAY SINGH RATHORE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Nagaraj Goud Bodige | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- 3 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2017)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
6 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Tap Pharmaceuticals Ag Switzerland | Joint Ventures | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 65 · Distress 80
Growth signals & trust indicators
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Operating for 17+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 0.86 in a year.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence84/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view76/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
29 Sep 2025
Director ceased
Nagaraj Goud Bodige
31 Mar 2025
Latest balance sheet
Filed with ROC
13 Mar 2025
Director appointed
Nagaraj Goud Bodige (Director)
29 Sep 2023
Director ceased
RAJEEV MUKUNDAN
Director ceased
AJAY SINGH RATHORE
05 Apr 2023
Director ceased
SANJEEV KUMAR SETHI
10 Feb 2023
Director appointed
AJAY SINGH RATHORE (Director)
Director ceased
JYOTIPRASAD TAPARIA
03 Nov 2022
Director ceased
SUNIL KASHIPRASAD KEDIA
Director ceased
MAHESH KUMAR LADHA
31 Mar 2021
Director ceased
SATISHCHANDRA GIRDHARILAL SHARMA
09 Mar 2021
Director ceased
URMILADEVI TAPARIA
23 Dec 2020
Securities allotted
156250 Equity Shares Without Differential Rights - 172.50 cr raised
04 Dec 2020
Securities allotted
156250 Equity Shares Without Differential Rights - 172.50 cr raised
10
Key Observations
Auto-generated from the data aboveRevenue declined 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
5 active GST registration(s) indicate ongoing business operations.
All 2 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 6 security allotment(s) - amounts available in the full report.
17 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Triumphmotorcycles | U93000HR2012FTC121771 | Bhondsi, Haryana, India |
| Ravel Electronics | U31903TN2003PTC051970 | Chennai, Tamil Nadu, India |
| Akgec- Kuka | U74991HR2006PTC036161 | Industrial Complex Dundahera, Haryana, India |
| Rsd Impex Traders Private Limited | U74110MH2010PTC205281 | Mumbai, Maharashtra, India |
| Barcelona Club | U17120GJ2015PLC084962 | Ahmadabad City, Gujarat, India |
| Shakuntla Jewellers Private Limited | U00383BR2006PTC012223 | Patna, Bihar, India |
| Shirode Cars Private Limited | U50102PN2012PTC144946 | Sangamner, Maharashtra, India |
| Thirupathi Steels Private Limited | U27320TZ2019PTC032802 | Salem, Tamil Nadu, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Famycare before audits and certifications: compliance score 86/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Famycare: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Famycare - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Famycare pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Famycare - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Famycare an active company?
Famycare has MCA status “Active” with a compliance score of 86/100 (Low Risk).
Is Famycare financially healthy?
Famycare has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.
Should I do business with Famycare?
Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Famycare?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Famycare have loans or charges against its assets?
No open charges - all 2 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Famycare up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 86/100 (Low Risk).
Is it risky to lend to Famycare?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
